### Johnson & Johnson’s $15 Billion Acquisition of Intra-Cellular Therapies Could Ignite a Flurry of Big Pharma Transactions Johnson & Johnson (J&J), the international healthcare powerhouse, has unveiled a deal to purchase neuroscientifically oriented biotech firm Intra-Cellular Therapies for an approximate $15 billion (£12 billion). This significant transaction, which focuses on pioneering solutions for central […]
Read More